Europe — EMA

Olmesartan Medoxomil Stada

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil Stada, is an angiotensin II receptor blocker presented as a unknown/unknown for oral use. It treats hypertension in adults.

Olmesartan Medoxomil

Request sourcing

Pack/s

What is Olmesartan Medoxomil?

Olmesartan medoxomil, the active ingredient in Olmesartan Medoxomil Stada, is an angiotensin II receptor blocker presented as a unknown/unknown for oral use. It treats hypertension in adults. GNH USA supplies Olmesartan Medoxomil Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomil Stada as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Olmesartan Medoxomil used for?

Olmesartan medoxil (note: spelling ) .... - Hypertension: Low ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - ... ... .... . - .... . - ... ...

What are the side effects of Olmesartan Medoxomil?

Common ....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →